AR/PCC alleviated diabetes-related osteoporosis by upregulating the antioxidant response protein (Nrf2) to reduce the activation of the NLRP3-mediated canonical pyroptosis pathway in vertebral osteoblasts. Here, NFE2L2 is linked to osteoporosis.